T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BERY
1076
DELISTED
Berry Global Group, Inc.
BERY
| $40.7M | ﹤0.01% |
722,143
-44,181
| -6% | -$2.29M |
|
1077
Sana Biotechnology
SANA
$1.1B
| $40.4M | ﹤0.01% |
+1,206,710
| New | +$39.3M |
|
|
CONE
1078
DELISTED
CyrusOne Inc Common Stock
CONE
| $40.3M | ﹤0.01% |
595,481
+391,051
| +191% | +$27.1M |
|
1079
Republic Services
RSG
$65.6B
| $40.3M | ﹤0.01% |
405,424
-12,806
| -3% | -$1.2M |
|
1080
International Seaways
INSW
$4.71B
| $40.2M | ﹤0.01% |
2,075,998
+515,046
| +33% | +$9.55M |
|
|
KAHC.U
1081
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
| $40M | ﹤0.01% |
+4,000,000
| New | +$40.1M |
|
1082
Expeditors International
EXPD
$24B
| $39.8M | ﹤0.01% |
369,199
-21,773
| -6% | -$2.1M |
|
1083
Perdoceo Education
PRDO
$1.96B
| $39.6M | ﹤0.01% |
3,312,565
+815,689
| +33% | +$10.3M |
|
1084
Steris
STE
$23B
| $39.6M | ﹤0.01% |
207,946
-9,060
| -4% | -$1.68M |
|
|
POSH
1085
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $39.5M | ﹤0.01% |
+973,865
| New | +$59.6M |
|
|
CHCT
1086
Community Healthcare Trust
CHCT
$430M
| $39.5M | ﹤0.01% |
855,618
+232,299
| +37% | +$10.8M |
|
1087
Fabrinet
FN
$20.3B
| $39.3M | ﹤0.01% |
435,064
-13,906
| -3% | -$1.2M |
|
|
CCF
1088
DELISTED
Chase Corporation
CCF
| $39.3M | ﹤0.01% |
337,440
-16,448
| -5% | -$1.84M |
|
1089
Labcorp
LH
$26.2B
| $39.1M | ﹤0.01% |
178,562
-11,449
| -6% | -$2.3M |
|
1090
Equity Bancshares
EQBK
$1.07B
| $39M | ﹤0.01% |
1,423,400
+2,471
| +0.2% | +$62.9K |
|
1091
Ormat Technologies
ORA
$6.97B
| $38.8M | ﹤0.01% |
494,310
-52,666
| -10% | -$5.21M |
|
1092
Hawkins
HWKN
$2.67B
| $38.7M | ﹤0.01% |
1,153,110
-2,156
| -0.2% | -$66.3K |
|
1093
ThredUp
TDUP
$416M
| $38.5M | ﹤0.01% |
+1,652,201
| New | +$40M |
|
1094
Hercules Capital
HTGC
$3.17B
| $38.5M | ﹤0.01% |
2,404,500
-18,437
| -0.8% | -$286K |
|
|
GTHX
1095
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $38.5M | ﹤0.01% |
1,598,848
+47,938
| +3% | +$1.11M |
|
1096
Graphic Packaging
GPK
$3.46B
| $38.5M | ﹤0.01% |
2,117,961
+247,155
| +13% | +$4.22M |
|
|
RNAM
1097
DELISTED
Avidity Biosciences
RNAM
| $38.3M | ﹤0.01% |
1,757,735
+812,897
| +86% | +$19.9M |
|
|
ACCD
1098
DELISTED
Accolade Inc
ACCD
| $38.1M | ﹤0.01% |
839,674
+66,945
| +9% | +$3.22M |
|
1099
Brinker International
EAT
$10.2B
| $38M | ﹤0.01% |
535,189
+391,351
| +272% | +$26.2M |
|
1100
Zymeworks
ZYME
$1.77B
| $37.4M | ﹤0.01% |
1,185,797
-5,062
| -0.4% | -$206K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.